And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We hope to catch up on a backlog of reading, spend time with our short people, and promenade with the official mascots. We can all use the exercise. And what about you? This is a good time to winterize your castle or boost the economy and buy a sweater. You can plan a quick getaway now that holiday season is here. Or if you are feeling brave, you could forecast the impact those tariffs may have on your budget. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Total retail prescription-drug spending, which is spending on drugs at a retail outlet or a physician office, rose 0.4 percent in 2017, compared with an increase of 2.3 percent in 2016. This was down from a 12.4 percent in 2014. And total spending last year was $333.4 billion, The Wall Street Journal writes, citing a report by the Centers for Medicare and Medicaid Services, which was published in Health Affairs. The deceleration in the rate of prescription drug spending was due, in part, to lower insulin prices in 2017 and a decline in spending on pain medications such as opioids.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy